02.02.2006 21:08:00

IMS Health to Host 2006 Investor Day on February 13 at 9:00 a.m. EST

IMS Health (NYSE: RX) will hold its 2006 Investor Day onFebruary 13, 2006 at The Marriott Marquis Hotel in New York City.Presenters will provide a strategic update and review of the business,and include David Carlucci, CEO and president; Nancy Cooper, seniorvice president and CFO; and Gilles Pajot, executive vice president andpresident, Global Business Management. The presentations will begin at9:00 a.m. EST, followed by demonstrations of IMS offerings andcapabilities, and a luncheon.

Investors are invited to listen to the sessions via teleconferenceor live Webcast. The dial-in numbers for the conference call are:
-- U.S. and Canadian participants: 1-888-313-7737

-- International participants: 1-212-676-5255

An audio replay of the conference call will be available beginningat 2:30 p.m. EST on February 13, 2006 and extend through February 20.The replay dial-in numbers are:
-- U.S. and Canadian participants: 1-800-633-8284

-- International participants: 1-402-977-9140

Reservation # 21282154

To listen to a live Webcast of the IMS presentations and to viewaccompanying slides, go tohttp://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=67124&eventID=1200961 (Due to its length, this URL may need to becopied/pasted into your Internet browser's address field. Remove theextra space if one exists.) or to the "Investors" area of the IMSwebsite at http://www.imshealth.com.

For additional details and registration information, contact TammyTobin by e-mail at RX_InvestorDay2006@imshealth.com or by phone at(203) 319-4761.

About IMS

Operating in more than 100 countries, IMS Health is the world'sleading provider of market intelligence to the pharmaceutical andhealthcare industries. With $1.8 billion in 2005 revenue and more than50 years of industry experience, IMS offers leading-edge businessintelligence products and services that are integral to clients'day-to-day operations, including portfolio optimization capabilities;launch and brand management solutions; sales force effectivenessinnovations; managed care and over-the-counter offerings; andconsulting and services solutions that improve ROI and the delivery ofquality healthcare worldwide. Additional information is available athttp://www.imshealth.com.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu IMS Health Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu IMS Health Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

S&P 500 5 918,25 0,16%
FTSE GLOB TECH 1 498,45 -3,25%